DE
LKFT

DV Equities’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

DV Equities’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$10.9K Buy
+332
New +$10.7K ﹤0.01% 620

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

DV Equities's LKFT Position: Q4 2025 in Review

DV Equities opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2025: 332 shares worth $10.9K. The stake represents ﹤0.01% of the portfolio and ranks #620 among its holdings.

90 funds tracked by Wall St. Rank hold LKFT as of Q4 2025.

  • DV Equities held 332 shares of Lakefront Biotherapeutics American Depositary Shares worth $10.9K as of Q4 2025.
  • Lakefront Biotherapeutics American Depositary Shares was a new DV Equities position in Q4 2025.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of DV Equities's portfolio in Q4 2025, its #620 holding.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2025.

Based on DV Equities's 13F filing for Q4 2025, filed 17 Feb 2026.